• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 住院成人的血栓栓塞事件在性别、种族和民族方面的差异。

Sex-, Race- and Ethnicity-Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID-19.

机构信息

Section of Vascular Surgery, Heart and Vascular Center Dartmouth-Hitchcock Medical Center Lebanon NH.

Section of Cardiovascular Medicine, Heart and Vascular Center Dartmouth-Hitchcock Medical Center Lebanon NH.

出版信息

J Am Heart Assoc. 2021 Dec 7;10(23):e022829. doi: 10.1161/JAHA.121.022829. Epub 2021 Nov 30.

DOI:10.1161/JAHA.121.022829
PMID:34845920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075407/
Abstract

Background Patients hospitalized with COVID-19 have an increased risk of thromboembolic events. Whether sex, race or ethnicity impacts these events is unknown. We studied the association between sex, race, and ethnicity and venous and arterial thromboembolic events among adults hospitalized with COVID-19. Methods and Results We used the American Heart Association Cardiovascular Disease COVID-19 registry. Primary exposures were sex and race and ethnicity, as defined by the registry. Primary outcomes were venous thromboembolic events and arterial thromboembolic events. We used logistic regression for risk adjustment. We studied 21 528 adults hospitalized with COVID-19 across 107 centers (54.1% men; 38.1% non-Hispanic White, 25.4% Hispanic, 25.7% non-Hispanic Black, 0.5% Native American, 4.0% Asian, 0.4% Pacific Islander, and 5.9% other race and ethnicity). The rate of venous thromboembolic events was 3.7% and was more common in men (4.2%) than women (3.2%; <0.001), and in non-Hispanic Black patients (4.9%) than other races and ethnicities (range, 1.3%-3.8%; <0.001). The rate of arterial thromboembolic events was 3.9% and was more common in men (4.3%) than women (3.5%; =0.002), and in non-Hispanic Black patients (5.0%) than other races and ethnicities (range, 2.3%-4.7%; <0.001). Compared with men, women were less likely to experience venous thromboembolic events (adjusted odds ratio [OR], 0.71; 95% CI, 0.61-0.83) and arterial thromboembolic events (adjusted OR, 0.76; 95% CI, 0.66-0.89). Compared with non-Hispanic White patients, non-Hispanic Black patients had the highest likelihood of venous thromboembolic events (adjusted OR, 1.27; 95% CI, 1.04-1.54) and arterial thromboembolic events (adjusted OR, 1.35; 95% CI, 1.11-1.65). Conclusions Men and non-Hispanic Black adults hospitalized with COVID-19 are more likely to have venous and arterial thromboembolic events. These subgroups may represent at-risk patients more susceptible to thromboembolic COVID-19 complications.

摘要

背景 患有 COVID-19 的住院患者发生血栓栓塞事件的风险增加。性别、种族或民族是否会影响这些事件尚不清楚。我们研究了成年 COVID-19 住院患者中性别、种族和民族与静脉和动脉血栓栓塞事件之间的关系。

方法和结果 我们使用了美国心脏协会心血管疾病 COVID-19 注册中心的数据。主要暴露因素是性别和种族和民族,由注册中心定义。主要结局是静脉血栓栓塞事件和动脉血栓栓塞事件。我们使用逻辑回归进行风险调整。我们研究了来自 107 个中心的 21528 名患有 COVID-19 的成年患者(54.1%为男性;38.1%为非西班牙裔白人,25.4%为西班牙裔,25.7%为非西班牙裔黑人,0.5%为美洲原住民,4.0%为亚洲人,0.4%为太平洋岛民,5.9%为其他种族和民族)。静脉血栓栓塞事件的发生率为 3.7%,男性(4.2%)比女性(3.2%)更常见(<0.001),非西班牙裔黑人患者(4.9%)比其他种族和民族更常见(范围为 1.3%-3.8%)(<0.001)。动脉血栓栓塞事件的发生率为 3.9%,男性(4.3%)比女性(3.5%)更常见(=0.002),非西班牙裔黑人患者(5.0%)比其他种族和民族更常见(范围为 2.3%-4.7%)(<0.001)。与男性相比,女性发生静脉血栓栓塞事件的可能性较小(调整后的优势比[OR],0.71;95%CI,0.61-0.83)和动脉血栓栓塞事件(调整后的 OR,0.76;95%CI,0.66-0.89)。与非西班牙裔白人患者相比,非西班牙裔黑人患者发生静脉血栓栓塞事件(调整后的 OR,1.27;95%CI,1.04-1.54)和动脉血栓栓塞事件(调整后的 OR,1.35;95%CI,1.11-1.65)的可能性最高。

结论 患有 COVID-19 的住院男性和非西班牙裔黑人成年人更有可能发生静脉和动脉血栓栓塞事件。这些亚组可能代表更容易发生 COVID-19 血栓栓塞并发症的高危患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1686/9075407/1da6bf60db6b/JAH3-10-e022829-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1686/9075407/d69f9aa5d6c6/JAH3-10-e022829-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1686/9075407/1da6bf60db6b/JAH3-10-e022829-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1686/9075407/d69f9aa5d6c6/JAH3-10-e022829-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1686/9075407/1da6bf60db6b/JAH3-10-e022829-g001.jpg

相似文献

1
Sex-, Race- and Ethnicity-Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID-19.COVID-19 住院成人的血栓栓塞事件在性别、种族和民族方面的差异。
J Am Heart Assoc. 2021 Dec 7;10(23):e022829. doi: 10.1161/JAHA.121.022829. Epub 2021 Nov 30.
2
Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry.因 COVID-19 住院患者的临床表现和结局的种族和民族差异:美国心脏协会 COVID-19 心血管疾病登记研究的结果。
Circulation. 2021 Jun 15;143(24):2332-2342. doi: 10.1161/CIRCULATIONAHA.120.052278. Epub 2020 Nov 17.
3
COVID-19 Hospitalization in Hawai'i and Patterns of Insurance Coverage, Race and Ethnicity, and Vaccination.夏威夷的 COVID-19 住院治疗情况以及保险覆盖范围、种族和族裔以及疫苗接种情况。
JAMA Netw Open. 2024 May 1;7(5):e243696. doi: 10.1001/jamanetworkopen.2024.3696.
4
Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.2020 年 3 月至 2021 年 2 月期间美国 COVID-19 相关住院率、重症监护病房入院率和住院死亡率的种族和民族差异。
JAMA Netw Open. 2021 Oct 1;4(10):e2130479. doi: 10.1001/jamanetworkopen.2021.30479.
5
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.纽约市一家城市医疗中心的 COVID-19 患者种族与合并症及生存率的关系。
JAMA Netw Open. 2020 Sep 1;3(9):e2019795. doi: 10.1001/jamanetworkopen.2020.19795.
6
Association of Human Mobility Restrictions and Race/Ethnicity-Based, Sex-Based, and Income-Based Factors With Inequities in Well-being During the COVID-19 Pandemic in the United States.美国在新冠大流行期间,人类活动限制以及基于种族/民族、性别和收入因素与幸福感不平等之间的关联。
JAMA Netw Open. 2021 Apr 1;4(4):e217373. doi: 10.1001/jamanetworkopen.2021.7373.
7
Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City.评估纽约市 COVID-19 患者住院和死亡的种族/民族差异。
JAMA Netw Open. 2020 Dec 1;3(12):e2026881. doi: 10.1001/jamanetworkopen.2020.26881.
8
Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.2009 年至 2019 年美国按种族和族裔划分的流感相关住院率、重症监护病房入院率和住院死亡率。
JAMA Netw Open. 2021 Aug 2;4(8):e2121880. doi: 10.1001/jamanetworkopen.2021.21880.
9
Vaccination Status and Trends in Adult Coronavirus Disease 2019-Associated Hospitalizations by Race and Ethnicity: March 2020-August 2022.疫苗接种状况和成人 2019 冠状病毒病相关住院率的种族和民族趋势:2020 年 3 月至 2022 年 8 月。
Clin Infect Dis. 2023 Sep 18;77(6):827-838. doi: 10.1093/cid/ciad266.
10
COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study.COVID-19 相关住院率和 5 家退伍军人事务医疗中心退伍军人的严重结局:基于医院的监测研究。
JMIR Public Health Surveill. 2021 Jan 22;7(1):e24502. doi: 10.2196/24502.

引用本文的文献

1
Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA.认识新冠疫情期间原住民的异质性:对加拿大、澳大利亚、新西兰和美国的一项范围综述
BMJ Public Health. 2024 Dec 30;2(2):e001341. doi: 10.1136/bmjph-2024-001341. eCollection 2024 Dec.
2
Sex Differences in Venous Thromboembolism after COVID-19 Infection: A Retrospective Population-based Matched Cohort Study.新冠病毒感染后静脉血栓栓塞的性别差异:一项基于人群的回顾性匹配队列研究
Ann Am Thorac Soc. 2024 Nov;21(11):1624-1628. doi: 10.1513/AnnalsATS.202401-070RL.
3
Gender and Race-Based Health Disparities in COVID-19 Outcomes among Hospitalized Patients in the United States: A Retrospective Analysis of a National Sample.

本文引用的文献

1
The most important biomarker associated with coagulation and inflammation among COVID-19 patients.与 COVID-19 患者凝血和炎症相关的最重要的生物标志物。
Mol Cell Biochem. 2021 Jul;476(7):2877-2885. doi: 10.1007/s11010-021-04122-4. Epub 2021 Mar 19.
2
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review.近期 COVID-19 患者抗血栓治疗的随机临床试验:美国心脏病学会最新综述。
J Am Coll Cardiol. 2021 Apr 20;77(15):1903-1921. doi: 10.1016/j.jacc.2021.02.035. Epub 2021 Mar 16.
3
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
美国住院患者中 COVID-19 结局的性别和种族健康差异:一项全国样本的回顾性分析
Vaccines (Basel). 2022 Nov 29;10(12):2036. doi: 10.3390/vaccines10122036.
4
Survival, reintervention and surveillance reports: long-term, centre-level evaluation and feedback of vascular interventions.生存、再次干预及监测报告:血管介入治疗的长期、中心层面评估与反馈
BMJ Surg Interv Health Technol. 2022 Oct 7;4(1):e000140. doi: 10.1136/bmjsit-2022-000140. eCollection 2022.
5
Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study.狼疮抗凝物与入住重症监护病房的COVID-19患者血栓形成相关:一项回顾性队列研究。
Res Pract Thromb Haemost. 2022 Sep 16;6(6):e12809. doi: 10.1002/rth2.12809. eCollection 2022 Aug.
6
Radiological Determinants of Thromboembolic Events in COVID-19 Pneumonia: A Retrospective Study.新冠病毒肺炎血栓栓塞事件的放射学决定因素:一项回顾性研究
Cureus. 2022 Aug 6;14(8):e27736. doi: 10.7759/cureus.27736. eCollection 2022 Aug.
7
Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic.西班牙一家三级医院在疫情爆发的前18个月内对所有住院COVID-19患者血栓形成事件的全面特征分析
J Clin Med. 2022 Jun 15;11(12):3443. doi: 10.3390/jcm11123443.
8
Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan.2019冠状病毒病大流行期间的心血管考量:日本实践的重点综述
Glob Health Med. 2022 Apr 30;4(2):101-107. doi: 10.35772/ghm.2022.01006.
9
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study.COVID-19 患者血栓形成中性别因素的影响:来自 CLOT-COVID 研究。
Thromb Res. 2022 May;213:173-178. doi: 10.1016/j.thromres.2022.03.023. Epub 2022 Mar 31.
COVID-19 重症监护患者中中剂量与标准剂量预防抗凝对血栓事件、体外膜肺氧合治疗或死亡率的影响:INSPIRATION 随机临床试验。
JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152.
4
Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach.新型冠状病毒肺炎中的凝血障碍与血栓栓塞性疾病:对当前证据的综述以寻求更好的方法
J Thorac Dis. 2021 Feb;13(2):1239-1255. doi: 10.21037/jtd-20-3062.
5
The Importance of Gender to Understand Sex Differences in Cardiovascular Disease.性别对理解心血管疾病中的性别差异很重要。
Can J Cardiol. 2021 May;37(5):699-710. doi: 10.1016/j.cjca.2021.02.005. Epub 2021 Feb 13.
6
The Groundwater of Racial and Ethnic Disparities Research: A Statement From .种族和族裔差异研究中的地下水:.的声明
Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007868. doi: 10.1161/CIRCOUTCOMES.121.007868. Epub 2021 Feb 11.
7
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.COVID-19 患者中中剂量抗凝、阿司匹林与住院死亡率:倾向评分匹配分析。
Am J Hematol. 2021 Apr 1;96(4):471-479. doi: 10.1002/ajh.26102. Epub 2021 Feb 22.
8
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.COVID-19 住院患者静脉血栓栓塞症和出血的发生率:系统评价和荟萃分析。
Chest. 2021 Mar;159(3):1182-1196. doi: 10.1016/j.chest.2020.11.005. Epub 2020 Nov 17.
9
Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy.新冠病毒感染后的性别相关差异:胸腺肽 α-1 治疗的意义。
Int Immunopharmacol. 2021 Jan;90:107022. doi: 10.1016/j.intimp.2020.107022. Epub 2020 Sep 18.
10
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.COVID-19 住院患者的抗凝、出血、死亡率和病理学。
J Am Coll Cardiol. 2020 Oct 20;76(16):1815-1826. doi: 10.1016/j.jacc.2020.08.041. Epub 2020 Aug 26.